Company News »

CONMED Announces the Passing of Its Founder, Eugene R. Corasanti

Business Wire
Share on StockTwits
Published on

It is with great sadness that CONMED Corporation (Nasdaq:CNMD) announces the passing of its founder, Eugene R. Corasanti. Gene founded the Company in 1970 and served as Chairman of the Board since its incorporation through February of 2014. Gene also served as the Company’s Chief Executive Officer from its founding through December 31, 2006.

Mark Tryniski, Chairman of the Board, stated, “No words can adequately express our sadness at Gene’s passing. Through Gene’s entrepreneurial spirit and leadership, CONMED grew from a small operation in Utica, New York to a publicly-traded company, with employees, customers and relationships around the globe. We are honored to have had the opportunity to work with him and will honor his memory by continuing to build the Company he loved so much. We extend our deepest sympathy to his wife, Connie, and the rest of Gene’s family.”

About CONMED Corporation

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. The Company distributes its products worldwide from several manufacturing locations. CONMED has a direct selling presence in 16 countries outside the United States and international sales constitute over 50% of the Company’s total sales. Headquartered in Utica, New York, the Company employs 3,500 people. For more information, visit

Forward-Looking Information

This press release contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. For example, all statements regarding the payment of cash dividends in future periods are forward-looking statements. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The forward-looking statements in this press release involve risks and uncertainties which could cause actual results, performance or trends, to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.

Share on StockTwits